Back to Journals » Therapeutics and Clinical Risk Management » Volume 18

Review

Once-Daily Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults and Adolescents Aged 12 Years and Over: A Short Review of Current Clinical Perspectives

       
Total article views   HTML views PDF downloads Totals
8,954 Dovepress* 6,266+ 368 6,634
PubMed Central* 2,688 417 3,105
Totals 8,954 785 9,739
*Since 13 April 2022

View citations on PubMed Central and Google Scholar